MICHAEL TAYLOR to Gene Deletion
This is a "connection" page, showing publications MICHAEL TAYLOR has written about Gene Deletion.
Connection Strength
0.224
-
BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma. J Clin Oncol. 2015 Mar 20; 33(9):1015-22.
Score: 0.092
-
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet. 2009 Apr; 41(4):465-72.
Score: 0.061
-
Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy. Nat Commun. 2020 04 14; 11(1):1825.
Score: 0.033
-
MyoD is a tumor suppressor gene in medulloblastoma. Cancer Res. 2013 Nov 15; 73(22):6828-37.
Score: 0.021
-
Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature. 2010 Jul 29; 466(7306):632-6.
Score: 0.017